Efficacy and safety of ABP 980 compared with reference trastuzumab in women with HER2-positive early breast cancer (LILAC study): a randomised, double-blind, phase 3 trial
Titel:
Efficacy and safety of ABP 980 compared with reference trastuzumab in women with HER2-positive early breast cancer (LILAC study): a randomised, double-blind, phase 3 trial
Auteur:
von Minckwitz, Gunter Colleoni, Marco Kolberg, Hans-Christian Morales, Serafin Santi, Patricia Tomasevic, Zorica Zhang, Nan Hanes, Vladimir